Gaetano Rocco, MD
Primary and Metastatic Tumors of the Lung, Chest Wall, Mediastinum, Pleura, and Airway; Lung Cancer; Minimally Invasive Surgical Techniques
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
New Patient Appointments
Scheduling a visit is easy. Click below or call us to get started.
Dr. Rocco accepts the following list of insurance providers. Select your insurance provider to see more details.
Memorial Sloan Kettering is an in-network provider with Aetna HMO, POS, and PPO plans. Aetna does not include us in any of the plans you can purchase through the insurance exchanges or through Medicare. Please ask your insurance if you need a one-time referral. MSK has an agreement with the Aetna Transplant Program for all Aetna's commercial products.
Memorial Sloan Kettering is a designated Blue Distinction Center for bone marrow transplant and CAR-T.
We understand that there may be many complexities involved with insurance coverage purchased through the health exchange network of the Affordable Care Act. We’re here to help. If you have questions about how your care will be covered by an insurance provider, or need help navigating a change in coverage, please call us at 646-227-3378; if you are not a resident of New York, you can call us at 866-248-1274. Our team is here to listen to your concerns and assist you in any way we can. We want our care to be as accessible and affordable for as many people as possible.
Memorial Sloan Kettering is an in-network provider with CIGNA's HMO, POS, and PPO plans. CIGNA does not include us in any of the plans you can buy through the insurance exchanges.
- If you are a New York State resident: Please ask your insurance if you need a one-time referral.
- If you live outside of New York State: Please ask your insurance if you have in-network access to Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with EmblemHealth’s PPO, EPO, POS, HMO plans. EmblemHealth includes GHI, HIP, Vytra, and ConnecticCare (in NYS Only). You must bring a referral from your Emblem primary care doctor to your first appointment. In-network participation exceptions include:
- Emblem’s HIP Commercial Millennium, Select Care and Enhanced Care Prime networks is not in-network with Memorial Sloan Kettering.
- Please call Emblem to confirm if your specific plan is in-network.
For information regarding Memorial Sloan Kettering’s participation with Emblem’s Medicare Advantage Plans, please refer to the Medicare & Medicaid page
Memorial Sloan Kettering is an in-network provider with Empire Blue Cross Blue Shield (Wellpoint) of New York Indemnity, HMO, EPO, PPO, POS and Medicare Advantage plans, with the following exceptions:
- Empire Blue Cross Blue Shield does not include us in any of the plans you can buy through the insurance exchanges.
- Please call Empire BCBS to confirm if your specific plan is in-network with Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with HealthFirst’s commercial products; these commercial products are not purchased on the insurance exchanges.
Memorial Sloan Kettering is an in-network provider with HealthSmart’s Accel, HSPC, and HPO networks.
For our NJ locations, Memorial Sloan Kettering is an in-network provider with most Horizon Blue Cross Blue Shield of New Jersey plans for individuals, families, and small businesses. Horizon members with Blue Card Access (there would be a suitcase logo on the front of the card) may have access to our NY locations. Please call Horizon to confirm if your plan is in-network in NY.
Memorial Sloan Kettering is a designated Center of Excellence by Humana.
Memorial Sloan Kettering is a designated Center of Excellence by Interlink Health Services.
Memorial Sloan Kettering is a designated Center of Excellence by Lifetrac.
Memorial Sloan Kettering is an in-network provider for all MagnaCare health plans except those products you can buy through the insurance exchanges.
For information about Medicare and Medicaid, please visit this page
Memorial Sloan Kettering is an in-network provider with some Multiplan/Beech Street/PHCS plans. Contact your insurance carrier to find out if your plan provides in-network access to Memorial Sloan Kettering.
Memorial Sloan Kettering is a designated Center of Excellence by Multiplan.
If you are covered by more than one insurance plan, you will want to determine your benefits from both plans. First, you need to determine which one is your primary insurance provider by contacting your employee benefits office or your insurance carriers. After you find out which is your primary insurance provider, you should then contact your insurance carrier to determine if you have access to Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with some MVP plans. Contact your insurance carrier to find out if your plan provides in-network access to Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider for New York State employees who have enrolled in UnitedHealthcare's Cancer Resource Services. If you have the Empire Plan, you should call Cancer Resources Services at 866-936-6002 to verify and enroll in this coverage.
Memorial Sloan Kettering is in-network with Oscar’s Circle Plus Network, a part of its Small Group Broad line that is offered only to select small business groups. Oscar does not include Memorial Sloan Kettering as an in-network provider for any of its individual plans. Please confirm eligibility with your insurance carrier.
Most Blue Cross Blue Shield plans include Memorial Sloan Kettering as an in-network provider. Contact your insurance company to confirm if Memorial Sloan Kettering is in-network.
We have agreements with several insurance companies that may provide additional coverage for cancer patients. These benefit programs include:
- AXA Assistance USA
- Beech Street
- Integrated Health Plans
- National Health Administrators
- National Preferred Provider Network
- UnitedHealthcare's Cancer Resource Services
- United Resource Network
- Veterans Choice Program
Memorial Sloan Kettering is an in-network provider with Oxford’s Freedom and Liberty plans as well as the Metro Plan (which is only offered to small business groups and no longer offered as individual plans). Please confirm with your insurance if you need a one-time referral. Note: Oxford’s Medicare Managed Care plan — Secure Horizon — does not include Memorial Sloan Kettering as an in-network provider. Oxford does not include us in any of the plans you can buy through the insurance exchanges.
Memorial Sloan Kettering is an in-network provider with the World Trade Center Health Program.
Memorial Sloan Kettering is an in-network provider with QualCare's PPO and HMO/POS network.
Memorial Sloan Kettering is a designated Center of Excellence by Specialty Care Management.
Hospital and physician services may be covered by TRICARE. Please call your TRICARE plan to confirm coverage at Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with UnitedHealthCare's HMO, POS, and PPO plans. Please confirm with your insurance if a one-time referral is needed.
UnitedHealthCare's Medicare Managed Care plan does not include Memorial Sloan Kettering as an in-network provider.
United does not include us in any of the plans you can buy through the insurance exchanges.
Memorial Sloan Kettering is a designated Center of Excellence by UnitedHealthcare.
Contact and Location
Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
MD, University of Milan, Italy
General Surgery – University of Milan Hospitals, Italy; Thoracic Surgery – University of Milan Hospitals, Italy
Advanced General Thoracic Surgery – Mayo Clinic, Rochester MN
General Surgery; Thoracic Surgery
I am a surgeon who cares for people with lung cancer. I specialize in treating lung nodules, pleural effusions, chest wall tumors, and cancer that has spread to the lungs from other parts of the body. Whenever possible, I use minimally invasive surgical procedures. These have been shown to reduce patients’ pain and discomfort and decrease their time in the hospital. I also have expertise in chest wall reconstruction following surgery to remove chest wall tumors.
As an experienced thoracic surgeon, I use the most-advanced techniques and standards of practice aimed at improving patient outcomes. I work with an outstanding team of dedicated professionals. Every year, I perform about 220 operations and care for more than 800 patients in my practice.
I offer all of the procedures available to treat thoracic cancer. These include the single-incision approach (uniportal access) to the chest, thoracoscopic surgery (also called video-assisted thoracic surgery, or VATS), and open chest wall resections and reconstructions. I work with my patients and other members of their care team to select the type of operation that will be most effective in treating their disease.
I am also involved in several clinical trials that have shown promise in managing thoracic conditions. My research includes studies of surgery combined with immunotherapy for the treatment of advanced lung cancer. I am also interested in exploring new technologies that improve lung cancer diagnosis and minimally invasive surgical techniques.
I was inspired to become a surgical oncologist by the ambition to contribute to the fight against cancer. When patients meet with me for the first time, my goal is to successfully address their concerns. These may range from questions about their prognosis or pain after surgery to how long it will take to return to their normal activities.
People with lung cancer can be confident in the individualized treatment plan they will receive in an environment like Memorial Sloan Kettering Cancer Center, which offers state-of-the-art technology and outstanding care. I hope that my patients feel reassured in knowing that I am a dependable, consistent, and skilled thoracic surgeon, and I do my best to bring a human touch to their care.
Outside of work, I enjoy spending time with my family. I also appreciate fine art, especially 16th- and 17th-century European paintings.
I hope that my patients feel confident in knowing that I am a dependable, consistent, and skilled thoracic surgeon and do my best to bring a human touch to their care.
Awards and Honors
- Lifetime Achievement Award, European Society of Thoracic Surgery (2022)
- Alumnus d’Honore, Hopital Marie-Lannelongue-Universite Sud, France (2011)
- Silver Medal “Aesculapius,” Italian Minister of Health for Professional Achievements (2006)
- Fellowship, Royal College of Surgeons of Edinburgh (FRCSEd – 2004)
- Clinical Trials Co-Investigated by Dr. Rocco
- A Phase II Study of Alectinib, Entrectinib, or Vemurafenib/Cobimetinib Therapy Before Surgery in Patients with Nonmetastatic Non-Small Cell Lung Cancer with Certain Molecular Changes
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Research and Publications
Rocco G. One-port (uniportal) video-assisted thoracic surgical resections—a clear advance. J Thorac Cardiovasc Surg. 2012 Sep;144(3):S27-31. doi: 10.1016/j.jtcvs.2012.06.006. Epub 2012 Jun 27.
Rocco G, Martucci N, La Manna C, Jones DR, De Luca G, La Rocca A, Cuomo A, Accardo R. Ten-year experience on 644 patients undergoing single-port (uniportal) video-assisted thoracoscopic surgery. Ann Thorac Surg. 2013 Aug;96(2):434-8. doi: 10.1016/j.athoracsur.2013.04.044. Epub 2013 Jun 19.
Rocco G, Martucci N, La Rocca A, La Manna C, De Luca G, Fazioli F, Mori S. Postoperative local morbidity and the use of vacuum-assisted closure after complex chest wall reconstructions with new and conventional materials. Ann Thorac Surg. 2014 Jul;98(1):291-6. doi: 10.1016/j.athoracsur.2014.04.022. Epub 2014 May 21.
Jones GD, Caso R, No JS, Tan KS, Dycoco J, Bains MS, Rusch VW, Huang J, Isbell JM, Molena D, Park BJ, Jones DR, Rocco G. Prognostic factors following complete resection of non-superior sulcus lung cancer invading the chest wall. Eur J Cardiothorac Surg. 2020;58(1):78-85.
Jones GD, Tan KS, Caso R, Dycoco J, Park BJ, Bott MJ, Molena D, Huang J, Isbell JM, Bains MS, Jones DR, Rocco G. Time-varying analysis of readmission and mortality during the first year after pneumonectomy. J Thorac Cardiovasc Surg. 2020;160(1):247-55.
Jones GD, Caso R, Choe G, Tan KS, Connolly JG, Dycoco J, Molena D, Park BJ, Huang J, Adusumilli PS, Bott MJ, Downey RJ, Travis WD, Jones DR, Rocco G. Intentional segmentectomy for clinical T1N0 non-small cell lung cancer: survival differs by segment. Ann Thorac Surg. 2021;111(3):1028-35.
Keshava HB, Tan KS, Dycoco J, Livschitz J, Bott MJ, Huang J, Rusch VW, Isbell JM, Molena D, Bains MS, Jones DR, Rocco G. How effective is neoadjuvant therapy followed by surgery for pathologic single-station N2 non-small cell lung cancer? Semin Thorac Cardiovasc Surg. 2021;33(1):206-16.
Ferguson BD, Jones GD, Skovgard M, Molena D, Huang J, Bott MJ, Sihag S, Park BJ, Adusumilli PS, Downey RJ, Isbell JM, Rusch VW, Bains MS, Jones DR, Rocco G. Is routine chest radiography necessary after endobronchial ultrasound-guided fine needle aspiration? Ann Thorac Surg. 2021 Aug;112(2):467-72.
Jones GD, Lengel HB, Hsu M, Tan KS, Caso R, Ghanie A, Connolly JG, Bains MS, Rusch VW, Huang J, Park BJ, Gomez DR, Jones DR, Rocco G. Management of synchronous extrathoracic oligometastatic non-small cell lung cancer. Cancers (Basel). 2021;13(8):1893.
Connolly JG, Fiasconaro M, Tan KS, Cirelli MA Jr, Jones GD, Caso R, Mansour DE, Dycoco J, No JS, Molena D, Isbell JM, Park BJ, Bott MJ, Jones DR, Rocco G. Postinduction therapy pulmonary function retesting is necessary before surgical resection for non-small cell lung cancer. J Thorac Cardiovasc Surg. 2022;164(2):389-97.
de Angelis P, Tan KS, Chudgar NP, Dycoco J, Adusumilli PS, Bains MS, Bott MJ, Downey RJ, Huang J, Isbell JM, Molena D, Park BJ, Rusch VW, Sihag S, Jones DR, Rocco G. Operative time is associated with postoperative complications after pulmonary lobectomy. Ann Surg. 2022 [In press].
Visit PubMed for a full listing of Dr. Rocco’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Gaetano Rocco discloses the following relationships and financial interests:
Intellectual Property Rights
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.